Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change.
Nicole L Pratt, Lisa M Kalisch Ellett, Janet K Sluggett...
https://pubmed.ncbi.nlm.nih.gov/27920248/Actively Recruiting
Led by RAK Medical and Health Sciences University · Updated on 2025-03-12
479
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating whether a pharmacist-led educational program can reduce the inappropriate use of proton pump inhibitors PPIs among adults aged 18 years and older with potentially unnecessary PPI prescriptions in Ras Al Khaimah. The study aims to see if this intervention can lower PPI use, improve patients quality of life, and reduce healthcare costs by comparing the intervention group to those receiving usual care. The study is interventional and involves education for both patients and physicians to promote evidence-based deprescribing practices. The study has two groups one receives a pharmacist-led educational intervention including brochures, videos, decision aids, and deprescribing algorithms aimed at encouraging appropriate PPI use. The other group continues with standard care without any pharmacist intervention during the six-month period. Physicians in the intervention group also receive educational materials and guidance to support deprescribing. After six months, educational materials will be offered to the control group. Participants will be followed for six months to track changes in PPI use, symptoms related to gastroesophageal reflux disease, quality of life, medication counts, potential adverse effects, attitudes toward deprescribing, and healthcare costs. Assessments include questionnaires such as the Gastroesophageal Reflux Disease Impact Scale and EuroQol 5-Dimension 5-Level survey. Researchers will monitor if patients stop or reduce PPI doses and evaluate cost-effectiveness and quality-adjusted life years gained over the study period.
CONDITIONS
RAK-PRIDE: Optimizing Proton Pump Inhibitor Use Through Education and Intervention
S
Syed Arman Rabbani
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
RAK Medical and Health Sciences University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive either a pharmacist-led educational intervention focused on appropriate use and deprescribing of proton pump inhibitors, or continue with their usual care without additional intervention.
Visits as per routine clinical care; educational materials provided to intervention arm
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Nicole L Pratt, Lisa M Kalisch Ellett, Janet K Sluggett...
https://pubmed.ncbi.nlm.nih.gov/27920248/Laura E Targownik, Deborah A Fisher, Sameer D Saini
https://pubmed.ncbi.nlm.nih.gov/35183361/Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara
https://pubmed.ncbi.nlm.nih.gov/29605975/Tom D Wilsdon, Ivanka Hendrix, Tilenka R J Thynne...
https://pubmed.ncbi.nlm.nih.gov/28220380/M Naunton, G M Peterson, L S Deeks...
https://pubmed.ncbi.nlm.nih.gov/28895169/Barbara Farrell, Kevin Pottie, Wade Thompson...
https://pubmed.ncbi.nlm.nih.gov/28500192/Barbara Clyne, Susan M Smith, Carmel M Hughes...
https://pubmed.ncbi.nlm.nih.gov/27255504/Naren Nallapeta, Jessica L Reynolds, Smita Bakhai
https://pubmed.ncbi.nlm.nih.gov/32091449/N Krol, M Wensing, F Haaijer-Ruskamp...
https://pubmed.ncbi.nlm.nih.gov/15080853/Gillian Giles, Heather Buchan, Carolyn Hullick...
https://pubmed.ncbi.nlm.nih.gov/39695003/RAK Medical and Health Sciences University
Lead Sponsor